SClurnge: Good to see you're hanging in there. We are getting dilution for sure, but it's undeniable PYC is growing as a company at the same time.
Look how far we've come in 12mths.
1 April 2010
- Roche stage 1 in progress
- MRC/Hutchison research on going
- CD40L progressing
- other in-house research on hold
1 April 2011
- Roche stage 1 successfully completed
- Roche fondling PYCs other bits to see what whistles
- Already months into AstraZeneca stage 1.
- Signed deal with Pfizer to find possible vaccines.
- Concluded initial stage with MRC/Hutchison
- PYC/Cambridge Uni developing startup company with cutting edge technology.
- CD40L progressing
- IMO in a matter of weeks this list could be out of date.
- did I miss anything
Our stake is diminishing in an expanding company.
ST
Ann: Appendix 3B 1st Tranche A , page-7
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $513.2M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.0¢ | $297.5K | 2.621M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 1372418 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 390472 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |